[Preprint] A Tetravalent Dengue Virus-like Particle Vaccine Induces High levels of Neutralizing Antibodies and Inhibits Dengue Replication in Non-Human Primates

VLP Therapeutics, Inc. (VLPT) researchers and their colleagues at Nagasaki University and the National Institute of Infectious Diseases in Japan posted on October 16 a preprint “A Tetravalent Dengue Virus-like Particle Vaccine Induces High levels of Neutralizing Antibodies and Inhibits Dengue Replication in Non-Human Primates” on bioRxiv, a preprint server for biology.

Note: Preprints are preliminary reports of work that have not been certified by peer review. They should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

• See the preprint abstract (full text also available): https://www.biorxiv.org/content/10.1101/2023.10.16.562563v1